Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2017 07:30 ET | Source: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, Aug. 08, 2017 (GLOBE NEWSWIRE) -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery,...
July 27, 2017 16:01 ET | Source: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Fourth Quarter and Full Year Financial Results

– Oral Plasma Kallikrein Inhibitor Portfolio for Treatment of Hereditary Angioedema Continues to Advance – – Intravitreal Diabetic Macular Edema Phase 2 On Track to Initiate in 2017 – CAMBRIDGE,...
June 01, 2017 07:30 ET | Source: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals to Present at Jefferies Healthcare Conference

CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, June 01, 2017 (GLOBE NEWSWIRE) -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery,...
March 16, 2017 16:15 ET | Source: KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Continuing to Develop a Portfolio of Oral Plasma Kallikrein Inhibitors for HAE –– Intravitreal DME Program Remains on Track for Phase 2 in 2017 –– Company Expects to be Well-Funded Through...